Genetic variants and risk for venous thromboembolic events: Summing up the evidence
Daniel Kurnik1,3; Aaron Lubetsky2,3
1Division of Clinical Pharmacology and Toxicology, and Department of Medicine A, Chaim Sheba Medical Center, Tel Hashomer, Israel; 2National Hemophilia Center and Institute of Thrombosis and Hemostasis, Department of Hematology, Chaim Sheba Medical Center, Tel Hashomer, Israel; 3Sackler Faculty of Medicine, Tel Aviv University, Israel
DOI
http://dx.doi.org/10.1160/TH09-06-0350